Petr Neuzil, M.D., Nemocnice Na Homolce Hospital, Prague, Czech Republic, presented three-month results from the WAVE II study and complete six-month results for the WAVE I (first-in-man) at the Transcatheter Cardiovascular Therapeutics conference (TCT 2013).


No law prevents doctors from freely prescribing U.S. Food and Drug Administration (FDA)-approved drugs and devices for off-label uses, yet regulators continue to aggressively pursue civil and criminal enforcement of perceived violations, warns Patrick J. Hurd, senior counsel with LeClairRyan in Washington, D.C. and Norfolk, Va. in the November 2013 edition of Westlaw Journal Pharmaceutical.
renal denervation clinical trial study hypertension cath medtronic symplicity

Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE), allowing the company to initiate SYMPLICITY HTN-4, the first randomized trial to investigate renal denervation for the treatment of moderate uncontrolled hypertension in U.S. patients.

Aycan will feature its mobile iPad application, which is designed to quickly, easily and securely transfer DICOM images from hospitals and imaging centers to on-call and other radiologists and referring physicians with an iPad, at the Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago. 

NEC Display Solutions will be offering additional insight and demonstrations of its latest products including the MultiSync MD210C2 medical-grade monitor, built for the displaying and viewing of digital images for diagnosis by physicians, at the Radiological Society of North America Annual Conference (RSNA 2013) in Chicago.

pacs cardiac NASA fujifilm wyle

Personnel of Wyle, a provider of engineering, scientific and technical service to the U.S. Department of Defense (DoD), at the Johnson Space Center have selected Fujifilm Medical Systems U.S.A. Inc. to implement Synapse Radiology and Synapse Cardiovascular to support NASA’s in-flight as well as ground-based clinical care operations.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now